top of page
Backgrounds.jpg

The voice of Colville and northeastern Washington since 1896

|

September 15, 2026

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

52.96 +2.52 (+5.00%)
Delayed Quote Updated: 10:25 AM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
37 38 Next >
News headline image
3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices
Beaten-down stocks offer value to investors, but not all are worth buying. This is a look at three biopharma at long-term lows with catalysts for higher prices. 
Via MarketBeat
News headline image
3 Profitable CRISPR Stocks Earning Analysts’ Praise ↗
Revolutionary gene-editing technologies provide promise for investors seeking the most profitable CRISPR stocks today and in the future. 
Via InvestorPlace
News headline image
7 Growth Stocks to Invest $500 In and Cash Out $100K by 2030 ↗
Investing $500 in these seven high-growth stocks could potentially turn into $100,000 by 2030, offering massive upside. 
Via InvestorPlace
News headline image
The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024 ↗
Finding undervalued gene editing stocks is easy, but having the patience to stick with them is the challenge. 
Via InvestorPlace
News headline image
The 3 Best Gene Editing Stocks to Buy in July 2024 ↗
Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks. 
Via InvestorPlace
News headline image
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow ↗
There are a handful of different factors that could buoy its stock. 
Via The Motley Fool
News headline image
Is CRISPR Therapeutics a Millionaire Maker? ↗
The stars are aligning for it to be a leader for years to come. 
Via The Motley Fool
News headline image
3 Pharma Stocks Already Ushering in the Next Biotech Boom ↗
So long as diseases afflict the human condition, there will likely always be a need for pharma stocks. Here are three to consider. 
Via InvestorPlace
News headline image
3 Top-Rated Gene Editing Stocks Actually Making Money ↗
Profitable gene editing stocks make increasingly compelling investments as therapies commercialize this year and beyond. 
Via InvestorPlace
News headline image
Trading SMID Biotech Stocks In A Volatile Market ↗
Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a... 
Via Talk Markets
News headline image
You’ve Been Warned! 3 Gene Editing Stocks to Buy Now or Regret Forever. ↗
The best gene editing stocks to buy are those with strong tehnogical applications and genuine commercialization prospects. 
Via InvestorPlace
News headline image
Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich ↗
These three biotech stocks to buy carry risks but may appeal to speculative investors with time and patience. 
Via InvestorPlace
News headline image
Is CRISPR Therapeutics Stock a Buy? ↗
The gene-editing therapy specialist is rising in prominence. 
Via The Motley Fool
News headline image
You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever. ↗
Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions. 
Via InvestorPlace
News headline image
Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued." ↗
The biotech's shares have traded sideways for over a year, but better days could be on the near-term horizon. 
Via The Motley Fool
News headline image
3 Biotech Stocks That Could Make Your Grandchildren Rich ↗
These biotech stocks are poised to generate significant returns to investors due to their high growth potential. 
Via InvestorPlace
News headline image
Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich ↗
Gene editing is a game-changer, creating substantial opportunities for some of the leading gene editing stocks. 
Via InvestorPlace
News headline image
3 Gene Editing Stocks That Could Make Your Grandchildren Rich ↗
Explore gene-editing stocks with long-term growth potential, offering innovative solutions to previously untreatable conditions. 
Via InvestorPlace
News headline image
The Next Big Thing After AI? 3 Sleeper Stocks to Buy Before the Boom ↗
These three sleeper stocks could deliver massive gains if their cutting-edge technologies take off in the coming years. 
Via InvestorPlace
News headline image
7 ‘FIRE’ Stocks to Put You on the Path to Financial Freedom ↗
With so many young people eager to get out of the corporate rat race, these FIRE stocks can accelerate your path and stay free. 
Via InvestorPlace
News headline image
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought ↗
These companies could generate explosive growth over time. 
Via The Motley Fool
News headline image
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You? ↗
In keeping with Cathie Wood's style, these picks are riskier than average. 
Via The Motley Fool
News headline image
Cathie Wood Has Been Steadily Selling Shares of This Growth Stock. Should You? ↗
Teladoc's share performance has reflected its earnings struggles... 
Via The Motley Fool
News headline image
7 Stocks You Haven’t Heard of (That EVERYONE Should Own) ↗
These under-the-radar must-own stocks across various sectors are using powerful megatrends and posting solid financial results. 
Via InvestorPlace
News headline image
7 Biotech Stocks to Put on Your Breakthrough Radar ↗
Although biotech stocks can present volatility risks due to its feast-or-famine nature, their narrative offers permanent relevance. 
Via InvestorPlace
News headline image
The 2030 Millionaire’s Club: 3 Biotech Stocks to Buy Now ↗
With interest cuts on the horizon, it's a prime time to consider these high-risk-high-reward biotech stocks to buy. 
Via InvestorPlace
News headline image
7 Must-Buy Stocks if You Only Have $1,000 to Spend: May Edition ↗
With a modest $1,000 investment, these stocks offer the potential for market-beating gains through solid fundamentals and growth prospects. 
Via InvestorPlace
News headline image
Bull Market Buys: 2 Growth Stocks to Own for the Long Run ↗
These biotech stocks have just launched their first products. 
Via The Motley Fool
News headline image
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 ↗
With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead. 
Via InvestorPlace
News headline image
7 No-Brainer Stocks to Buy and Hold for the Next 20 Years: May 2024 ↗
Here are seven stocks to buy and hold that are poised for long-term growth over the next 20 years and can future-proof your portfolio. 
Via InvestorPlace
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page